These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13635872)

  • 1. [Relation between zymosan, properdin & tumors. I. Effect of zymosan on the development of benzpyrene-induced sarcomas].
    MODICA F
    Tumori; 1958; 44(6):538-48. PubMed ID: 13635872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas].
    MODICA F; FUMAROLA D
    Tumori; 1958; 44(6):549-54. PubMed ID: 13635873
    [No Abstract]   [Full Text] [Related]  

  • 4. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interrelations of zymosan, properdin & tumors. IV. Behavior of mucopolysaccharides in the blood in benzopyrene sarcoma-bearing rats].
    MODICA F
    Tumori; 1959; 45(1):54-9. PubMed ID: 13659610
    [No Abstract]   [Full Text] [Related]  

  • 6. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptation of the zymosan assay of properdin to animal sera.
    KENT JF; TOUSSAINT AJ; HOOK WA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):676-8. PubMed ID: 13505826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
    SZABO IK
    Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylactic shock in zymosan pre-treated guinea-pigs. (A study on the possible role of properdin)].
    WILHELM RE; SALVAGGIO J; KRUPP I
    Int Arch Allergy Appl Immunol; 1961; 18():318-29. PubMed ID: 13831364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of zymosan on tumor growth in experimental animals].
    LUHRS W; HEISE E; BERNDT H
    Z Krebsforsch; 1958; 62(5):516-8. PubMed ID: 13625832
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z; WACHTL I; SZY S; SELLEI G
    Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of the method of determination of properdin in human serum by the zymosan method].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
    [No Abstract]   [Full Text] [Related]  

  • 13. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
    ANDREEVA ZM; NIKITINA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
    [No Abstract]   [Full Text] [Related]  

  • 15. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
    J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in serum properdin levels following injection of Zymosan.
    PILLEMER L; ROSS OA
    Science; 1955 May; 121(3151):732-3. PubMed ID: 14372981
    [No Abstract]   [Full Text] [Related]  

  • 19. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C; TASCHINI P; SELVA G; ORTOLANI C
    Boll Ist Sieroter Milan; 1958; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract]   [Full Text] [Related]  

  • 20. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L
    J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.